GlassScriptPhysician profile
Lisa Ellen Mcdaniel
NPI 1477933026
$712.13
in general payments reported to CMS, 2019-2025
11 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.88 · 2023: $49.68 · 2024: $330 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $334.35 | 2023-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $108.28 | 2024 | |
| Hologic Sales and Service, LLC | $67.99 | 2024-2025 | Aptima |
| Novo Nordisk INC | $57.33 | 2025 | Wegovy |
| Redhill Biopharma INC. | $28.94 | 2025 | Talicia |
| Lilly USA, LLC | $25.27 | 2025 | Zepbound, Mounjaro |
| Si-Bone, INC. | $24.80 | 2024 | |
| Dexcom, INC. | $21.33 | 2024 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $16.69 | 2025 | Veozah |
| Merck Sharp & Dohme LLC | $14.27 | 2025 | Enflonsia, Capvaxive, Rotateq |
| Sanofi Pasteur INC. | $12.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.